Skip to content

Public FDA record

Z-1628-2023: VITROS Chemistry Products HbA1c Reagent Kit- IVD for the quantitative determination of percent glycated h

Recall record Z-1628-2023 for Ortho-Clinical Diagnostics, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1628-2023
Company in FDA record
Ortho-Clinical Diagnostics, Inc.
FDA classification date
May 24, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Potential for both unexpected positive and negative HbA1c results, may result in misdiagnosis

Source facts

Action
Ortho Clinical Diagnostics (Ortho) issued to Dealers and End-Users Urgent Product Correction Notification Potential Bias Observed in VITROS Chemistry Products HbA1c Reagent Kit on 4/17/23. Letter states reason for recall, health risk and action to take: In an abundance of caution, the required actions are applicable to all lots within expiry ( as well as future lots until your laboratory receives an additional notification from Ortho. However, while data is limited, a review of the release testing indicated no other lots were impacted. Reagent Pack Used for Calibration o If your system currently has multiple HbA1c reagent packs, leave one reagent pack on the system and unload all other reagent packs and store at 2-8 oC (36-46 oF) until needed. o Calibrate the one HbA1c reagent pack on your system. o Perform QC after successful calibration. QC must be acceptable and subsequently performed every 8 hours of testing, for the first 2 days that the reagent pack is onboard the system. o If QC fails with a negative bias, troubleshoot according to your laboratory s procedure. o If QC fails with a positive bias, load a new pack and re-calibrate following the required actions. Review the patient results since the last passing QC by your Medical Director. o After 2 days of passing within your laboratory s established QC range, performing QC every 8 hours is no longer necessary on that pack. Refer to Testing section below for QC requirements after calibration. Reagent Pack Loading Only have one reagent pack loaded onboard your VITROS System at a time. " Reagent Pack Used for Testing o Once the reagent pack used for calibration is depleted, QC must be performed upon loading each reagent pack and must be within the laboratory s established QC range prior to patient testing. o If the QC results are outside your laboratory s established range with a negative bias, then discard that reagent pack and load a new pack to perform QC again. o Ortho s observed data does not demonstrate
Initiated
2023-04-17
Root cause
Under Investigation by firm
Distribution
US Nationwide- Worldwide Distribution. Foreign: Australia Belgium Brazil Bermuda HM12 Canada L3R 4G5 Chile China Colombia Denmark France France Germany India Italy Japan Mexico Norway Portugal Russia Singapore 609917 Spain Sweden The Netherlands United Kingdom
Recall number
Z-1628-2023
Recall status
Open, Classified
CDRH record ID
200002
FDA classified
2023-05-24
Recall event number
92254

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗